🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ankara
Clinical trial register · Turkey

Clinical Trials in Ankara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5432 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:51 UTC
5432
Studies in scope
all four open statuses
2496
Recruiting now
open to new participants
552
Lead sponsors
across recruiting studies
Top sites
Istanbul 2009 Ankara 1457 Izmir 568 Adana 378 Antalya 259
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hacettepe University132 AstraZeneca102 Merck Sharp & Dohme LLC91 Ankara City Hospital Bilkent73 Ankara Etlik City Hospital64
Site location
Istanbul2009 Ankara1457 Izmir568 Adana378 Antalya259
All 319 locations
Target enrolment
to

Trials with a site in Ankara

1457 of 5432 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Active, closed
Effects of Expressive Art Therapy Applied to Earthquake Victims Who Have Experienced Loss
NCT07010861Earthquake Victims
Merve Kızılırmak Tatu
Not applicable
42
Ankara
2024-06-15
Active, closed
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
NCT06305754Non-small Cell Lung Cancer (NSCLC)
DrugsSteroid mouthwash (dexamethasone·Acetaminophen·Sacituzumab tirumotecan·Pemetrexed
Merck Sharp & Dohme LLC
Phase 3
550
Adana, Ankara, Izmir
2024-06-11
Active, closed
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
NCT06472076Lung Cancer, Non-Small Cell
DrugsBelrestotug·Dostarlimab·Pembrolizumab
GlaxoSmithKline
Phase 3
88
Adana, Ankara
2024-06-10
Recruiting
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
NCT06422143Non-small Cell Lung Cancer, NSCLC
DrugsSacituzumab tirumotecan·Nab-paclitaxel·Keytruda·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
851
Stanbul, Ankara, Izmir, Kayseri, Mersin, Samsun
2024-06-10
Recruiting
Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
NCT06707792Renal Transplanted Recipients
Hacettepe University
Observational
40
Ankara
2024-06-09
Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
NCT06056297Neutropenia
X4 Pharmaceuticals
Phase 3
176
Tekirdağ, Ankara, Nilufer, Samsun
2024-06-06
Active, closed
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer
DrugsTarlatamab·Durvalumab
Amgen
Phase 3
563
Ankara, Istanbul, Izmir, Mersin, Sakarya
2024-06-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801Crohn's Disease
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 3
1,200
Bornova, Ankara, Antalya, Eskişehir, Istanbul, Kocaeli
2024-06-05
By invitation
Gait Pattern Analysis After Arthroscopic Treament of Osteochondral Defects of Talus
NCT07161128Osteochondral Defects of Talus, Gait Analysis, Microfracture Procedure, Biological Scaffold
Gazi University
Not applicable
60
Ankara
2024-06-01
Recruiting
Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
NCT07737340HIV Infections, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH), Fatty Liver
Yaşar Bayındır, MD
Observational
411
Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, Kocaeli
2024-06-01
Recruiting
Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy
NCT07101731Prostate Cancer (Post Prostatectomy), Urinary Incontinence, Erectile Dysfunction Following Radical Prostatectomy, Pelvic Floor Muscle Training
Bartın Unıversity
Not applicable
30
Ankara
2024-06-01
Active, closed
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT06470438Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL
Janssen Research & Development, LLC
Phase 1
58
Ankara, Istanbul
2024-05-28
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Bornova, Merkez, Ankara, Fatih, Istanbul, Izmir, Sarıçam, Umraniye
2024-05-24
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
NCT06345729Non-small Cell Lung Cancer
DrugsCalderasib·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
600
Bornova, Adana, Ankara, Istanbul
2024-05-24
Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06203210Small Cell Lung Cancer
DrugsAmrubicin·Ifinatamab Deruxtecan·Lurbinectedin·Topotecan
Daiichi Sankyo
Phase 3
540
Ankara, Diyarbakır, Istanbul, Izmir
2024-05-21
Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
NCT06353386Prostatic Neoplasms, Castration-Resistant
DrugsFludrocortisone acetate·Opevesostat·Cabazitaxel·Olaparib
Merck Sharp & Dohme LLC
Phase 1/2
220
Adana, Ankara, Istanbul
2024-05-20
Active, closed
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06158841Multiple Myeloma
DrugsElotuzumab·Etentamig·Carfilzomib·Selinexor
AbbVie
Phase 3
421
Şişli, Ankara, Antalya, Edirne, Istanbul
2024-05-19
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Ankara, Fatih, Istanbul, Zonguldak
2024-05-15
Recruiting
Effectiveness of High Intensity Laser Therapy (HILT) in Patients With Chronic Lumbar Radiculopathy Due to Disc Herniation.
NCT06651775Lumbar Radiculopathy
Ankara City Hospital Bilkent
Not applicable
70
Ankara
2024-05-15
By invitation
The Effect of Two Different Oral Care Solutions on Ventilator-Associated Pneumonia and Oral Health of Mechanically Ventilated Patients in the Intensive Care Unit
NCT06966817Ventilator-associated Pneumonia and Oral Health
DrugChlorhexidine
Saglik Bilimleri Universitesi
Not applicable
60
Ankara
2024-05-15
Recruiting
Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer
NCT06245343Lung Cancer
Gazi University
Not applicable
40
Ankara
2024-05-15
Active, closed
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
NCT06079359Hypophosphatasia
DrugALXN1850
Alexion Pharmaceuticals, Inc.
Phase 3
30
Ankara, Bursa, Erzurum, Istanbul
2024-05-14
Recruiting
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
NCT05795140Atypical Hemolytic Uremic Syndrome
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
65
Ankara, Mersin
2024-05-08
Recruiting
Can Lumbar Mulligan Mobilization Improve Gait, Balance, and Trunk Position Sense After Stroke?
NCT06887114Balance Impairments in Stroke Patients
Gulhane School of Medicine
Not applicable
40
Ankara
2024-05-08
Active, closed
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
DrugNerandomilast
Boehringer Ingelheim
Phase 3
1,666
Ankara, Antalya, Çapa, Yenimahalle/ANKARA
2024-05-06
Active, closed
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311Gastroesophageal Cancer
DrugsTrifluridine/Tipiracil·Sacituzumab tirumotecan·Irinotecan·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
450
Adana, Ankara, Diyarbakır, Erzurum, Istanbul, Samsun, Van
2024-05-03
Active, closed
Pulmonary Function, Muscle Strength, and Functional Capacity in Minimally Invasive Cardiac Surgery
NCT07172529Cardiac Surgery, Muscle Weakness | Patient, Pulmonary Function, Functional Capacity
Zehra Can Karahan
Observational
40
Ankara
2024-05-01
Recruiting
8-Week Artificial Intelligence Based Structured Exercises
NCT06508294Health Behavior
Hacettepe University
Not applicable
36
Ankara
2024-05-01
Recruiting
Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension
NCT06454838Pulmonary Arterial Hypertension
Gazi University
Observational
26
Ankara
2024-04-30
Active, closed
The Effect of Acupuncture on Sarcopenia and Obesity in Patients With Sarcopenic Obesity.
NCT07797140Sarcopenic Obesity, Acupuncture Treatment, Exercise
Ayşe Ukbe Baykut
Not applicable
28
Ankara
2024-04-30
Active, closed
Accessory Movements and Associated Factors During Active Cervical Range of Motion
NCT07267507Asymptomatic Condition, Neck Pain
Atılım University
Observational
180
Ankara
2024-04-30
Recruiting
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
NCT06361537Acute Hereditary Angio Edema
Octapharma
Phase 3
124
Ankara, Istanbul, Izmir, Sakarya
2024-04-30
By invitation
A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)
NCT06431893Homocystinuria
DrugPegtibatinase
Travere Therapeutics, Inc.
Phase 3
100
Ankara, Bornova, Istanbul
2024-04-30
Active, closed
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
DrugRetatrutide
Eli Lilly and Company
Phase 3
10,000
Afyonkarahisar, Ankara, Antalya, Bornova, Çorum, Edirne, Eskişehir, Gaziantep
2024-04-30
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT06350097Non-small Cell Lung Cancer
DrugsDatopotamab deruxtecan·Osimertinib
AstraZeneca
Phase 3
582
Adapazarı, Ankara, Goztepe Istanbul, Izmir, Küçükçekmece, Seyhan
2024-04-29
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961End Stage Kidney Disease
DrugClazakizumab
CSL Behring
Phase 2/3
3,110
Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit
2024-04-27
Active, closed
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
NCT05972551Osteogenesis Imperfecta
DrugRomosozumab
Amgen
Phase 3
111
Ankara, Istanbul, Izmir, Trabzon
2024-04-22
Active, closed
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
NCT06194448Lung Cancer
DrugsTagrisso·Osimertinib·Pemetrexed·Paclitaxel
AstraZeneca
Phase 2
76
Ankara, Yenimahalle
2024-04-21
Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
NCT06319820Non-Muscle Invasive Bladder Neoplasms
DrugGemcitabine
Janssen Research & Development, LLC
Phase 3
641
Adana, Ankara, Istanbul, Izmir
2024-04-18
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Ankara, Eskişehir, Istanbul, Izmir, Kocaeli, Konya, Kütahya, Mersin
2024-04-16
Recruiting
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
NCT06341933Acute Kidney Injury, Surgery, Lung Cancer
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Observational
100
Ankara
2024-04-15
Active, closed
Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites
NCT06375837Tooth Diseases
Hacettepe University
Not applicable
33
Ankara
2024-04-15
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176Breast Neoplasms
DrugsLiposomal doxorubicin·Sacituzumab tirumotecan·Nab-paclitaxel·Capecitabine
Merck Sharp & Dohme LLC
Phase 3
1,200
Yenimahalle, Stanbul, Adana, Ankara, Istanbul, Samsun
2024-04-14
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652Heart Failure and Impaired Kidney Function
AstraZeneca
Phase 3
3,850
Adana, Ankara, Antalya, Bursa, Center, Dinar, Eskişehir, Istanbul
2024-04-12
Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
NCT06357533Non-Small Cell Lung Cancer
DrugsRilvegostomig·Datopotamab deruxtecan·Keytruda·Pembrolizumab
AstraZeneca
Phase 3
675
Adapazarı, Ankara, Antalya, Diyarbakır, Istanbul
2024-04-11
Active, closed
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
NCT06307431Renal Cell Carcinoma
DrugsIntismeran autogene·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2
272
Ankara, Izmir
2024-04-10
Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
NCT06330064Recurrent or Metastatic Solid Tumors
DrugIfinatamab Deruxtecan
Daiichi Sankyo
Phase 1/2
680
Bağcılar, Ankara, Izmir
2024-04-10
Recruiting
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT06236438Non-Small Cell Lung Cancer
DrugsLivmoniplimab·Budigalimab·Pemetrexed·Cisplatin
AbbVie
Phase 2/3
840
Ankara, Izmir
2024-04-10
Recruiting
Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness
NCT06706492Renal Transplantation
Hacettepe University
Observational
30
Ankara
2024-04-06
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Bornova, Adana, Ankara
2024-04-03
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Non Small Cell Lung Cancer
DrugsSacituzumab tirumotecan·Pemetrexed·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
780
Korfez Mahallesi, Adana, Ankara, Istanbul, Kayseri
2024-04-03
Active, closed
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
NCT06079372Hypophosphatasia
DrugsAsfotase alfa·ALXN1850
Alexion Pharmaceuticals, Inc.
Phase 3
43
Altındağ, Ankara, Edirne, Erzurum, Istanbul
2024-04-02
Active, closed
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
NCT06200207Heart Failure, Systemic Inflammation
DrugZiltivekimab
Novo Nordisk A/S
Phase 3
680
Eskişehir, Adana, Afyonkarahisar, Ankara, Bursa, Edirne, Istanbul, Kayseri
2024-04-01
Active, closed
Effect of Local Estriol Treatment Before Vaginal Repair Surgery
NCT06391372Pelvic Organ Prolapse, Pelvic Floor Disorders, Menopause, Vaginal Atrophy
DrugEstriol
Hatice Tukenmez Kurnaz
Phase 3
36
Ankara
2024-04-01
Recruiting
Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases
NCT06756633Neuromuscular Diseases in Children, Respiratory Function Impaired, Respiratory Insufficiency, Duchenne Muscular Dystrophy
Lokman Hekim University
Observational
42
Ankara
2024-04-01
By invitation
Effects of Therapeutic Artistic Activities on the Mental Status of Adolescents Followed Up with Diabetes Diagnosis
NCT06595173Adolescent, Diabetes
Gazi University
Not applicable
70
Ankara
2024-04-01
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
579
Ankara, Bursa, Istanbul, Kayseri, Kocaeli, Konya
2024-03-29
Active, closed
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
NCT06268873Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
2,554
Adana, Adapazarı, Afyonkarahisar, Ankara, Antalya, Bursa, Istanbul, Kahramanmaraş
2024-03-29
Active, closed
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
NCT06305767Bladder Cancer
DrugsIntismeran autogene·Enfortumab Vedotin·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 1/2
230
Ankara, Istanbul, Izmir
2024-03-28
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588Neoplasms, Head and Neck
DrugDostarlimab
GlaxoSmithKline
Phase 3
864
Adapazarı, Ankara, Antalya, Istanbul
2024-03-21
Recruiting
Effect of Transauricular Vagal Stimulation on Cardiac Function After Spinal Cord Injury
NCT07007884Spinal Cord Injury (SCI)
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Not applicable
30
Ankara
2024-03-20
Active, closed
Evaluating Universal Adhesives in Cervical Lesions
NCT07459374Cervical Lesion, Dental
Hacettepe University
Not applicable
30
Ankara
2024-03-19
Active, closed
Comparison of Music and Ambient Noise Cancellation in Patients Undergoing Total Knee Arthroplasty (TKA)
NCT06401018Knee Osteoarthritis, Anxiety, Post Operative Pain, Noise Exposure
Ankara City Hospital Bilkent
Not applicable
90
Ankara
2024-03-15
Recruiting
Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema.
NCT06264817Lymphedema of Upper Limb
Thuasne
Not applicable
40
Ankara
2024-03-15
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310Systemic Lupus Erythematosus
DrugAnifrolumab
AstraZeneca
Phase 3
100
Ankara, Istanbul, Kayseri, Umraniye
2024-03-14
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Adana, Ankara, Bursa, Center, Fatih, Gaziantep, Istanbul, Izmir
2024-03-13
Active, closed
A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
NCT06348199Non-small Cell Lung Cancer Stage IV
DrugsKeytruda·Pembrolizumab
Samsung Bioepis Co., Ltd.
Phase 3
555
Adapazarı, Ankara, Bağcılar, Balgat, Çubuk, Istanbul, İzmit, Kavaklıdere
2024-03-12
Active, closed
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
NCT06346392Gastric Cancer, Gastroesophageal Junction Cancer
DrugsSonesitatug Vedotin·Ramucirumab·Trifluridine/Tipiracil·Apatinib
AstraZeneca
Phase 3
594
Ankara, Diyarbakır, Erzurum, Istanbul
2024-03-04
Active, closed
Evaluation of Post-Induction Hypotension Treatment with PRAM Method
NCT06787404Hypotension on Induction
DrugsNoradrenalin·Ephedrine
Ankara City Hospital Bilkent
Observational
100
Ankara
2024-03-01
Active, closed
The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery
NCT06684015Cesarean Delivery, Postoperative Pain, Cytokine Levels, Chronic Pain, Postoperative
Ankara University
Observational
110
Ankara
2024-03-01
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT05827081Early Breast Cancer
DrugsLeuprolide·Goserelin·Exemestane·Ribociclib
Novartis Pharmaceuticals
Phase 3
1,400
Sakarya, Ankara, Istanbul, Izmir, Denizli, Antalya, Diyarbakır, Adana
2024-02-28
Recruiting
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT05935215Atypical Hemolytic Uremic Syndrome
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
50
Izmir, Köseköy, Ankara, Mersin
2024-02-28
Active, closed
From Perception to Performance: A Comprehensive Evaluation in Knee Osteoarthritis.
NCT07417033Osteoarthritis, Pain, Function, Knee Joint Arthritis
Lokman Hekim University
Observational
100
Ankara
2024-02-28
Active, closed
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003Duchenne Muscular Dystrophy, Exon 44, DMD
DrugBrogidirsen
NS Pharma, Inc.
Phase 2
20
Ankara, Istanbul, Izmir
2024-02-22
Recruiting
Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation
NCT06591702Chronic Kidney Disease(CKD), Chronic Kidney Disease Requiring Chronic Dialysis, Kidney Transplantation
Hacettepe University
Observational
150
Ankara
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Ankara, Istanbul, Izmir, Kocaeli, Mersin, Samsun
2024-02-20
Recruiting
Pressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients
NCT05960604Cardiovascular Diseases, Surgery, Hypotension, Hypotension on Induction
Recep Tayyip Erdogan University
Observational
660
Ankara, Erzurum, Istanbul, Rize
2024-02-19
Active, closed
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
NCT06120140Carcinoma, Non-Small-Cell Lung
DrugsClobetasol·Minocycline·Chlorhexidine·Clindamycin
Janssen Research & Development, LLC
Phase 2
305
Adana, Ankara, Istanbul, Izmir, Samsun
2024-02-16
Active, closed
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
NCT06230224B-Cell Non-Hodgkin Lymphoma (B-NHL)
DrugsOdronextamab·Ifosfamide·Paraplatin·Cytarabine
Regeneron Pharmaceuticals
Phase 3
216
Mamak, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Sakarya, Samsun
2024-02-15
Recruiting
Single-Window Versus Two-Window Posterolateral Approach for Malleolar Fractures
NCT07481266Ankle Fractures, Posterior Malleolus Fractures, Lateral Malleolus Fracture
muhammed kılıç
Not applicable
100
Ankara
2024-02-14
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Adapazarı, Ankara, Battalgazi, Çankaya, Istanbul, Kepez, Mezitli, Ortahisar
2024-02-05
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Ankara, Istanbul, Edirne, Izmir
2024-02-01
Recruiting
Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes
NCT06635590Chronic Kidney Disease (CKD), Hyperkalemia, Hemodialysis
Saglik Bilimleri Universitesi
Observational
40
Ankara
2024-02-01
Active, closed
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
NCT06143891Chronic Graft Versus Host Disease
DrugsBelumosudil·Prednisolone·Prednisone
Sanofi
Phase 3
260
Adana, Ankara, Istanbul, Izmir
2024-01-23
Active, closed
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
NCT06208150Multiple Myeloma
DrugsElotuzumab·Velcade·Talquetamab·Teclistamab
Janssen Research & Development, LLC
Phase 3
838
Ankara, Denizli, Istanbul, Samsun
2024-01-22
Active, closed
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
NCT06260163Colitis, Ulcerative
DrugsTremfya·Guselkumab
Janssen Research & Development, LLC
Phase 3
112
Ankara, Istanbul
2024-01-19
Active, closed
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
NCT06018337Metastatic Breast Cancer
DrugsDB-1303/BNT323·Nab-paclitaxel·Capecitabine·Paclitaxel
DualityBio Inc.
Phase 3
541
Adana, Ankara, Diyarbakır, Istanbul, Izmir, Mersin, Samsun
2024-01-18
Recruiting
Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls
NCT06631261Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
Hacettepe University
Observational
60
Ankara
2024-01-18
Active, closed
A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
NCT06268613Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage IIIA
DrugsEU sourced Keytruda·US-sourced Keytruda·Pembrolizumab
Samsung Bioepis Co., Ltd.
Phase 1
163
Adana, Ankara, Istanbul, Izmir
2024-01-16
Recruiting
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
NCT05970172Chronic Kidney Disease, Renal Anemia
DrugRoxadustat
Astellas Pharma Global Development, Inc.
Phase 3
100
Ankara, Istanbul, İzmit, Kayseri, Manisa
2024-01-16
Active, closed
RZ358 Treatment for Congenital Hyperinsulinism
NCT06208215Congenital Hyperinsulinism
Rezolute
Phase 3
56
Ankara
2024-01-11
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugALXN2220
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Ankara, Dinar, Eskişehir, Istanbul, Mersin
2024-01-11
Recruiting
STOP-Bang Questionnaire: A Predictor of Obstructive Sleep Apnea and Difficult Mask/Intubation?
NCT06247631Difficult Intubation, Airway Disease
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Observational
125
Ankara
2024-01-10
Active, closed
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
NCT06105632Advanced or Metastatic Breast Cancer
DrugsExemestane·Everolimus·Fulvestrant
Pfizer
Phase 2
333
Stanbul, Ankara
2024-01-09
Active, closed
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa
NCT06079281Hypophosphatasia
DrugALXN1850
Alexion Pharmaceuticals, Inc.
Phase 3
124
Ankara, Yakutiye
2024-01-03
Recruiting
Internal Jugular Vein Ultrasound for Predicting Hypotension in Geriatric Patients Undergoing Spinal Anesthesia
NCT07411313Spinal Anesthesia Induced Hypotension, Geriatric, Internal Jugular Vein, Ultrasonography
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Observational
85
Ankara
2024-01-03
Active, closed
Topical Treatments for Ankle Sprains
NCT06623929Ankle Sprain
DrugDiclofenac
Ankara City Hospital Bilkent
Observational
100
Ankara
2024-01-01
By invitation
Evaluation of the Effectiveness of Developmental Hip Dysplasia Screening in Risk Groups
NCT07066852Developmental Dysplasia of Hip
Ankara City Hospital Bilkent
Observational
300
Ankara
2024-01-01
Active, closed
Effect of Different Root Canal Preparation Sizes and Remaining Tooth Structure on the Survival of Endodontically Treated Mandibular Molars
NCT07583004Periapical Healing, Restoration Survival
Saglik Bilimleri Universitesi
Not applicable
60
Ankara
2024-01-01
Recruiting
Effects of the CO-OP Approach on Occupational Performance and Executive Function in Adults With Stroke
NCT07127536Stroke
Hacettepe University
Not applicable
66
Ankara
2024-01-01
Rows per page Showing 901–1000 of 1457
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-turkey/city/ankara?page=10

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,432 studies in total at the last sync on 26 Sep 2026, 19:51 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,457 of those studies with a site in Ankara.

How many clinical trials are recruiting in Ankara?

706 of the 1,457 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:51 UTC sync. A further 176 have not yet opened recruitment, 513 are active but closed to new participants, and 62 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.